What is Spectral AI, Inc.'s market cap?

Spectral AI, Inc. (MDAI) has a market capitalization of $54.7M and trades on NASDAQ.

What is Spectral AI, Inc.'s revenue and profitability?

Spectral AI, Inc. generated $16.9M in trailing twelve-month revenue with a net loss of $12.0M, representing a net margin of -70.0%. Gross margin stands at 46.0%. These figures are based on the Q1 2026 filing.

Who are Spectral AI, Inc.'s competitors?

Spectral AI, Inc.'s key competitors include Hyperfine, Inc. Class A Common Stock, OneMedNet Corp Class A Common Stock, Aclarion, Inc. Common Stock, and others. These companies compete in similar markets and product categories.

Who does Spectral AI, Inc. partner with?

Spectral AI, Inc.'s notable partners include PolyNovo, Ltd., Biomedical Advanced Research and Development Authority (BARDA), Defense Health Agency (DHA), and others.

Where is Spectral AI, Inc. headquartered?

Spectral AI, Inc. is headquartered in United States of America and employs approximately 78 people. It has been publicly traded since 2023.

Spectral AI, Inc.

MDAI

Spectral AI is a predictive medical diagnostics company that utilizes artificial intelligence and multispectral imaging to assess wound healing potential.

Market cap

$54.74M-31.2%

Revenue$16.9M-43.5%

Net income-$12.0M+20.6%

EPS (diluted)-$0.44+47.6%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 12, 2026

Revenue$4.0MMiss by $134.0K EPS-$0.11In line

Read the full report

Next report

Aug 11, 2026 (in a month)

Revenue estimate$4.7M

EPS estimate-$0.16

Financials

Q1 2026

Income statement

See full

Revenue$4.0M-40.5%

Gross profit$2.0M-36.0%

Operating income-$2.0M-120%

Net income-$3.4M-218%

EPS (diluted)-$0.11-200%

Balance sheet

See full

Cash & equivalents$11.7M-17.1%

Total debt$6.0M-36.6%

Total equity-$8.8M-442%

Total assets$17.7M-14.4%

Cash flow

See full

Operating cash flow-$3.7M-148%

Valuation & ratios

Valuation

See full

Market cap$54.74M-31.2%

Enterprise value$49.11M-28.9%

P/S3.2×+0.7×

Profitability

See full

Gross margin46%+0.9pp

Operating margin-57.2%-104pp

Returns & leverage

See full

Current ratio0.8×-0.7×

Competitors

By market cap

GE HealthCare Technologies$29.4B-13.8%

Organogenesis Holdings Inc.$316.5M-41.3%

Hyperfine, Inc.$111.7M+87.5%

Odysight.ai$72.3M—

Spectral AI, Inc.$54.7M-21.8%

OneMedNet$43.2M+69.6%

Heart Test Laboratories, Inc.$8.8M+115%

Aclarion, Inc.$7.2M+58.8%

By revenue growth

Hyperfine, Inc.+30.7%

Organogenesis Holdings Inc.+12.2%

GE HealthCare Technologies+6.0%

Spectral AI, Inc.-43.5%

Odysight.ai-82.3%

By net margin

GE HealthCare Technologies9.1%-1.9pp

Organogenesis Holdings Inc.0.528%+4.0pp

Spectral AI, Inc.-69.96%-20.5pp

Hyperfine, Inc.-226.88%+117pp

Odysight.ai-1,739.44%-1,519pp

Profile

Spectral AI is a predictive medical diagnostics company that utilizes artificial intelligence and multispectral imaging to assess wound healing potential. Its core value proposition is the DeepView System, which provides clinicians with an objective, binary 'Day One' assessment of whether a wound will heal or not, significantly reducing the traditional 'wait and see' observation period.

Competitive position

The company is a first-mover in AI-enabled predictive wound healing diagnostics, leveraging a proprietary database of over 340 billion pixels to create a significant barrier to entry.

GeographiesUnited States, United Kingdom, Australia, European Union

Customer segmentsHospitals, Government Agencies, Military, Outpatient Clinics

Business modelSaaS, SaMD, Hardware Sales, Government Contracting

SuppliersContract Manufacturers, Optics and Sensor Suppliers, Electronic Component Providers, Cloud Hosting Services

CustomersFederal and Community Hospitals, Department of Defense, National Health Service (NHS), Specialized Burn and Trauma Centers

CountryUnited States of America

Listed2023

Employees78.0

CEOVincent S. Capone

SectorHealthcare

IndustryMedical - Devices

Websitespectralmd.com

FilingsSEC EDGAR

Ask your AI about Spectral AI, Inc..

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Spectral AI, Inc.'s market cap?: Spectral AI, Inc. (MDAI) has a market capitalization of $54.7M and trades on NASDAQ.
What is Spectral AI, Inc.'s revenue and profitability?: Spectral AI, Inc. generated $16.9M in trailing twelve-month revenue with a net loss of $12.0M, representing a net margin of -70.0%. Gross margin stands at 46.0%. These figures are based on the Q1 2026 filing.
Who are Spectral AI, Inc.'s competitors?: Spectral AI, Inc.'s key competitors include Hyperfine, Inc. Class A Common Stock, OneMedNet Corp Class A Common Stock, Aclarion, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
Who does Spectral AI, Inc. partner with?: Spectral AI, Inc.'s notable partners include PolyNovo, Ltd., Biomedical Advanced Research and Development Authority (BARDA), Defense Health Agency (DHA), and others.
Where is Spectral AI, Inc. headquartered?: Spectral AI, Inc. is headquartered in United States of America and employs approximately 78 people. It has been publicly traded since 2023.